The new Ethicon factory has attracted a total investment of $180 million.
Johnson & Johnson broke ground for its new Ethicon factory on Thursday in Suzhou of East China’s Jiangsu province, in an attempt to address the health problems faced in the country.
The new Ethicon factory has attracted a total investment of $180 million. The factory will be responsible for the manufacturing of Johnson & Johnson’s patented medical devices, such as triclosan-coated sutures, endoscopic staplers and linear cutters. These surgical products will be used to treat critical diseases such as lung cancer, liver cancer and gastric cancer.
